Advertisement
News
Subscribe to MDT Magazine News

Morphine Sulfate Oral Solution 100 mg per 5 mL (20 mg/mL): Medication Use Error - Reports of Accidental Overdose

January 10, 2011 11:30 am | by U.S. Food & Drug Administration | Comments

Morphine sulfate oral solution ordered in milligrams (mg) were mistakenly interchanged for milliliters (mL) of the product.

TOPICS:

TSX-listed corporate dividends and distributions declared Jan. 10, 2010

January 10, 2011 10:45 am | by The Associated Press | Comments

Dividends or distributions were declared or updated on the followed listed issues on the Toronto Stock Exchange on January 10, 2011.Canadian Convertible Debenture Fund Units (TSX:CDF.UN): $0.0625. Payable Jan 14. Record Dec 31.Cdn Energy Convertible Debenture Fnd Trans Un (TSX:CFE.UN):...

Nopras Technologies, Inc. Achieves ISO 9001:2008 Certification

January 10, 2011 10:35 am | by Bio-Medicine.Org | Comments

NOVI, Mich., Jan. 10, 2011 /- Nopras Technologies, Inc., a globally recognized management consulting firm which specializes in services for organizations in the Pharmaceutical, Biotechnology, Medical Device and other FDA regulated industries announced on January 10th, 2011 that it has...

TOPICS:
Advertisement

Hotspur Technologies Continues to Bring Innovations to Peripheral Vascular Market

January 10, 2011 10:33 am | by Bio-Medicine.Org | Comments

MOUNTAIN VIEW, Calif., Jan. 10, 2011 /- Hotspur Technologies, Inc. announced today that Dr. Bruce Lin, M.D., and Dr. Stephen Liu, M.D., Interventional Radiologists at Lifelink Interventional Center in Modesto, California, performed the first commercial deployment of the company's...

TOPICS:

Teleflex buys VasoNova for $55 million

January 10, 2011 9:45 am | by The Associated Press | Comments

Teleflex Inc., a maker of medical and aerospace equipment, said Monday it bought privately-held VasoNova for $55 million, gaining technology used for catheter placement.Venous catheters are tubes inserted into a vein and used to deliver fluids or medication. VasoNova is based in Menlo Park,...

Celgene 2011 profit forecast misses analyst views

January 10, 2011 9:45 am | by The Associated Press | Comments

Biotechnology company Celgene Corp. issued preliminary fourth-quarter results Monday, and gave a profit forecast for 2011 that fell short of analyst expectations.It also said its board authorized the repurchase of up an additional $500 million in stock.Celgene said it expects net income of 40...

Volcano revenue outlook tops 4Q expectations

January 10, 2011 8:45 am | by The Associated Press | Comments

Medical device maker Volcano Corp. said Monday it expects to report revenue of about $81 million for the fourth quarter, which would top Wall Street expectations.The company said it gained more market share in the fourth quarter as use of its devices that help doctors see inside heart vessels...

Thermo Fisher gets antitrust OK for Dionex deal

January 10, 2011 8:45 am | by The Associated Press | Comments

Thermo Fisher Scientific Inc. said it received antitrust approval for its $2.1 billion acquisition of laboratory equipment maker Dionex Corp., bringing it one step closer to completing the deal.The scientific instrument maker said Monday that it is seeking similar clearances under antitrust...

Advertisement

JCI online early table of contents: Jan. 10, 2011

January 10, 2011 7:38 am | by EurekAlert | Comments

(Journal of Clinical Investigation) This press release summarizes the contents of the JCI's Jan. 10, 2011, issue.

TOPICS:

Exergen TemporalScanner Sponsors 'Game Time Temperature' for NFL and College Bowl Games

January 10, 2011 7:36 am | by Bio-Medicine.Org | Comments

WATERTOWN, Mass., Jan. 10, 2011 /- Drawing attention to its TemporalScanner™ Temporal Artery Thermometer during flu season, Exergen® Corporation is sponsoring "game-time temperature" for national radio broadcasts of NFL games and the upcoming College Bowl football games. The...

TOPICS:

MedAvante Names Leading Expert to Head Neurocognition Therapeutic Area

January 10, 2011 7:35 am | by Bio-Medicine.Org | Comments

HAMILTON, N.J., Jan. 10, 2011 /- MedAvante, Inc., the leader in centralized expert evaluation of treatments for central nervous system (CNS) disorders, announced the appointment of Christopher Randolph, PhD, ABPP-CN, to the new position of Vice President, Neurocognition.  Dr....

TOPICS:

Gilead Sciences extends study of HIV drug

January 10, 2011 6:45 am | by The Associated Press | Comments

Gilead Sciences Inc. said Monday that, at the recommendation of the Food and Drug Administration, it will double the length of its late-stage study of HIV drug candidate elvitegravir to almost two years.Gilead said the study, which compares elvitegravir to Merck & Co.'s drug Isentress, will now...

Mindray estimates 2010 profit grew 10 percent

January 10, 2011 6:45 am | by The Associated Press | Comments

Mindray Medical International Ltd. said Monday it estimates that its adjusted profit in 2010 grew about 10 percent greater than its profit in 2009.The Shenzhen, China, company also said it estimates its revenue grew about 10 percent. In 2009, Mindray reported a profit of $147.4 million, or...

Ceapro Announces Debt Reduction

January 10, 2011 4:45 am | by The Associated Press | Comments

Ceapro Inc. (TSX VENTURE: CZO) today announced that pursuant to a debt settlement agreement made with the members of its board of directors previously announced on December 13, 2010, it has issued 1,590,909 common shares in full satisfaction of debts totaling $175,000. The shares issues...

Kinetic Concepts buys TechniMotion Medical

January 10, 2011 4:45 am | by The Associated Press | Comments

Medical technology company Kinetic Concepts Inc. said Monday it acquired TechniMotion Medical, which develops patient handling systems for acute and post-acute care. Terms of the deal were not disclosed.Kinetic, which is based in San Antonio, said TechniMotion products include lifts for...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading